Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Johnson currently holds 698,083 shares of MELINTA THERAPEUTICS, INC. /NEW/ (MLNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Johnson has been a net seller of MLNT stock. They have purchased $258.8K and sold $3.3M worth of shares.
John Johnson's most recent insider trade was on Dec 19, 2025, when they sold 135,400 shares at $7.22 per share.
John Johnson serves as Executive at MELINTA THERAPEUTICS, INC. /NEW/ (MLNT). They have executed 74 insider transactions totaling $3.5M over their tenure at the company.
John Johnson holds the position of Executive at MELINTA THERAPEUTICS, INC. /NEW/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
John Johnson has shown a selling trading pattern, with $258.8K in total purchases and $3.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Johnson was on Dec 19, 2025, when they sold $977.6K worth of XERS shares. This transaction involved 135,400 shares at $7.22 per share.
John Johnson currently owns 698,083 shares of MELINTA THERAPEUTICS, INC. /NEW/ (MLNT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Johnson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Johnson has 74 Form 4 filings on record as an insider at MELINTA THERAPEUTICS, INC. /NEW/.
Set alerts for John Johnson and 40,000+ other insiders.